Dendritic Cell Reprogramming by Endogenously Produced Lactic Acid
Open Access
- 15 September 2013
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 191 (6), 3090-3099
- https://doi.org/10.4049/jimmunol.1300772
Abstract
The demand for controlling T cell responses via dendritic cell (DC) vaccines initiated a quest for reliable and feasible DC modulatory strategies that would facilitate cytotoxicity against tumors or tolerance in autoimmunity. We studied endogenous mechanisms in developing monocyte-derived DCs (MoDCs) that can induce inflammatory or suppressor programs during differentiation, and we identified a powerful autocrine pathway that, in a cell concentration–dependent manner, strongly interferes with inflammatory DC differentiation. MoDCs developing at low cell culture density have superior ability to produce inflammatory cytokines, to induce Th1 polarization, and to migrate toward the lymphoid tissue chemokine CCL19. On the contrary, MoDCs originated from dense cultures produce IL-10 but no inflammatory cytokines upon activation. DCs from high-density cultures maintained more differentiation plasticity and can develop to osteoclasts. The cell concentration–dependent pathway was independent of peroxisome proliferator–activated receptor γ (PPARγ), a known endogenous regulator of MoDC differentiation. Instead, it acted through lactic acid, which accumulated in dense cultures and induced an early and long-lasting reprogramming of MoDC differentiation. Our results suggest that the lactic acid–mediated inhibitory pathway could be efficiently manipulated in developing MoDCs to influence the immunogenicity of DC vaccines.Keywords
This publication has 31 references indexed in Scilit:
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Current Status and Future Applications of Cellular Therapies for CancerImmunotherapy, 2011
- Harnessing dendritic cells in cancerSeminars in Immunology, 2011
- Dendritic cells in cancer immunotherapyEuropean Journal of Immunology, 2010
- Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma PatientsClinical Cancer Research, 2009
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinThe Journal of Experimental Medicine, 2008
- Maximizing dendritic cell migration in cancer immunotherapyExpert Opinion on Biological Therapy, 2008
- Tumor-derived lactic acid modulates dendritic cell activation and antigen expressionBlood, 2006
- Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinomaThe Journal of Experimental Medicine, 2005
- Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor EvasionCancer Research, 2005